These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22002034)

  • 1. Use of octreotide in the treatment of chylothorax and chyloperitoneum.
    Pessotti CF; Jatene IB; Buononato PE; Elias PF; Pinto AC; Kok MF
    Arq Bras Cardiol; 2011 Aug; 97(2):e33-6. PubMed ID: 22002034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can octreotide be the first line treatment for chylothorax?
    Leelahanon S; Petlek W; Sontimuang W; Pochanart P; Tepakorn V; Ruangpeg S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S741-5. PubMed ID: 14700175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Propranolol in the Treatment of Chylous Effusions in Infants.
    Mitchell K; Weiner A; Ramsay P; Sahni M
    Pediatrics; 2021 Jul; 148(1):. PubMed ID: 34187907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous neonatal chylothorax treated with octreotide.
    Siu SL; Lam DS
    J Paediatr Child Health; 2006; 42(1-2):65-7. PubMed ID: 16487393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octreotide in the treatment of congenital chylothorax.
    Rasiah SV; Oei J; Lui K
    J Paediatr Child Health; 2004; 40(9-10):585-8. PubMed ID: 15367160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of chylothorax with octreotide after congenital heart surgery.
    Tatar T; Kilic D; Ozkan M; Hatipoglu A; Aslamaci S
    Thorac Cardiovasc Surg; 2011 Aug; 59(5):298-301. PubMed ID: 21394709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide for management of chylothorax following bidirectional Glenn in a three-month-old infant.
    Wright SB; Mainwaring RD
    J Card Surg; 2009; 24(2):216-8. PubMed ID: 19267835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chylothorax in children after congenital heart surgery.
    Chan SY; Lau W; Wong WH; Cheng LC; Chau AK; Cheung YF
    Ann Thorac Surg; 2006 Nov; 82(5):1650-6. PubMed ID: 17062221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide as therapeutic option for congenital idiopathic chylothorax: a case series.
    Shah D; Sinn JK
    Acta Paediatr; 2012 Apr; 101(4):e151-5. PubMed ID: 22092874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide treatment of chylothorax in pediatric patients following cardiothoracic surgery.
    Caverly L; Rausch CM; da Cruz E; Kaufman J
    Congenit Heart Dis; 2010; 5(6):573-8. PubMed ID: 21106017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe congenital chylothorax treated with octreotide.
    Young S; Dalgleish S; Eccleston A; Akierman A; McMillan D
    J Perinatol; 2004 Mar; 24(3):200-2. PubMed ID: 15044932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide treatment for chylothorax after congenital heart surgery.
    Tavli V; Yilmazer MM; Guven B; Mese T; Lafci B; Gurbuz A
    J Card Surg; 2009; 24(5):570-1. PubMed ID: 19740301
    [No Abstract]   [Full Text] [Related]  

  • 13. Octreotide infusion for the treatment of chylothorax in pediatric cardiac intensive care unit.
    Yildirim SV; Kervancioğlu M; Saritaş B; Varan B; Mercan S; Tokel K
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):317-8. PubMed ID: 16330401
    [No Abstract]   [Full Text] [Related]  

  • 14. Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report.
    Berzigotti A; Magalotti D; Cocci C; Angeloni L; Pironi L; Zoli M
    Dig Liver Dis; 2006 Feb; 38(2):138-42. PubMed ID: 16389001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octreotide Use in Neonates: A Case Series.
    Zaki SA; Krishnamurthy MB; Malhotra A
    Drugs R D; 2018 Sep; 18(3):191-198. PubMed ID: 29948779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invited commentary.
    Pelletier GJ
    Ann Thorac Surg; 2006 Nov; 82(5):1656-7. PubMed ID: 17062222
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful management of chylous ascites with total parenteral nutrition and octreotide in children.
    Yang C; Zhang J; Wang S; Li CC; Kong XR; Zhao Z
    Nutr Hosp; 2013 Nov; 28(6):2124-7. PubMed ID: 24506391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide--additional conservative therapy for postoperative chylothorax in congenital heart disease.
    Paramés F; Freitas I; Fragata J; Trigo C; Pinto MF
    Rev Port Cardiol; 2009; 28(7-8):799-807. PubMed ID: 19894659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis.
    Namba M; Masuda T; Nakamura T; Horimasu Y; Miyamoto S; Nakashima T; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Intern Med; 2017 Dec; 56(24):3327-3331. PubMed ID: 29021448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide efficacy in the treatment of chylothoraces following cardiac surgery in infants and children.
    Landvoigt MT; Mullett CJ
    Pediatr Crit Care Med; 2006 May; 7(3):245-8. PubMed ID: 16575348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.